Considering the concept of “One Health,” the aim of this study was to determine susceptibility profiles of Escherichia coli in piglets' intestinal microbiota from different farms in Portugal. Beyond antimicrobial susceptibility, the occurrence of multiple antibiotic resistance and detection of phenotypic/genotypic extended-spectrum beta-lactamases (ESBLs) and plasmid mediated AmpC beta-lactamases (pAmpC) were done. From 10 different pig farms, 340 E. coli isolates were obtained from 75 feces samples. Susceptibility to amoxicillin-clavulanic acid (AMC), piperacillin (PIP), cefoxitin (FOX), ceftazidime (CAZ), cefepime (FEP), aztreonam (AZT), imipenem (IP), amikacin (AK), ciprofloxacin (CIP), and trimethoprim-sulfamethoxazole (SXT) was determined. Five-gene panel for amplification of bla genes was used for ESBL (TEM, SHV, CTX-M) and pAmpC (CMY-2, ACC). Among E. coli isolates, 209 were distributed in three resistance profiles: 57.7% MDR, 3.5% extensively drug-resistance (XDR) (resistant to CIP, SXT, and beta-lactams, except IP, with variability to AK) and 0.3% pandrug-resistance (PDR) (resistant to all antibiotics used). pAmpC and/or ESBLs genes were presented in 65% of the isolates. Presence of different associations of bla genes in the same isolate was the most observed (31%), and the most common were an ESBL (TEM) and a pAmpC (CMY-2). Presence of three or four bla genes in various associations were detected. These isolates were very resistant, especially those with four genes, which were resistant to beta-lactams (except IP), CIP, and SXT. This study showed a surprisingly high rate of MDR E. coli isolated in Portuguese piglets, with enzymes that impair activity of the most used antibiotics in human therapeutic.
Get full access to this article
View all access options for this article.
References
1.
TangK.L., CaffreyN.P, NóbregaD.B, et al.2017. Restriction the use of antibiotics in food-producing animals and its associations with antibiotic resistance in food-producing animals and human beings: a systematic review and meta-analysis. Lancet Planet Health, 1:e316–27.
2.
Van BoeckelT.P., BrowerC., GilbertN., et al.2015. Global trends in microbial use in food animals. PNAS, 112:5649–5654.
European Parliament and the Council of the European Union. 2003. Regulation (EC) No 1831/2003. Off. J. Eur. Union L 268/29-42.
7.
CollignonP.J., and McEwenS.A. 2019. One Health-its importance in helping to better control antimicrobial resistance. Trop. Med. Infect. Dis, 4:22.
8.
WaseemH., WilliamsM.R, StedtfeldR.D, and HashshamS.A.. 2017. Antimicrobial resistance in the environment. Water Env. Res. 89:921–941.
9.
Mughini-GrasL., Dorado-GarcíaA., van DuijkerenE., et al.2019. Attributable sources of community-acquired carriage of Escherichia coli containing β-lactam antibiotic resistance genes: a population-based modelling study. Lancet Planet Health, 3:357–369.
10.
MobasseriG., TheC.S.J, OoiP.T, TanS.C, and ThongK.L.. 2019. Molecular characterization of multi-drug resistant and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated from swine farms in Malaysia. Microbial. Drug Resist. 25:1087–1098.
11.
LeeS., MirR.A, ParkS.H, et al.2020. Prevalence of extended-spectrum β-lactamases in the local farm environment and livestock: challenges to mitigate antimicrobial resistance. Crit. Rev. Microbiol. 46:1–14.
12.
EFSA (European Food Safety Authority) and ECDC (European Centre for Disease Prevention and Control). 2019. The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2017. EFSA J. 17:5598, 278 pp.
13.
EFSA (European Food Safety Authority) and ECDC (European Centre for Disease Prevention and Control),. 2020. The European Union Summary Report on Antimicrobial Resistance in zoonotic and indicator bacteria from humans, animals and food in 2017/2018. EFSA J. 18:6007, 166 pp.
14.
BushK.2018. Past and present perspectives on beta-lactamases. Antimicrob. Agents Chemother. 62:e01076-18.
15.
Dorado-GarcíaA., SmidJ.H, van PeltW., et al.2018. Molecular relatedness of ESBL/AmpC-producing Escherichia coli from humans, animals, food and the environment: a pooled analysis. J. Antimicrob. Chemother. 73:339–347.
16.
The European Committee on Antimicrobial Susceptibility Testing. 2019. Breakpoint tables for interpretation of MICs and zone diameters. Version 9.0. Available at www.eucast.org accessed October30, 2020.
17.
MagiorakosA.-P., SrinivasanA., CareyR.B, et al.2012. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18:268–281.
18.
Thomson, K.S. 2010. Extended-spectrum β-lactamase, AmpC, and carbapenemase issues. J. Clin. Microbiol. 48:1019–1025.
19.
QinX., ZerrD.M, WeissmanS.J, et al.2008. Prevalence and mechanisms of broad-spectrum β-lactam resistance in Enterobacteriaceae: a children's hospital experience. Antimicrob. Agents Chemother. 52:3909–3914.
20.
Lewis IIJ.S., HerreraM., WickesB., PattersonJ.E, and JorgensenJ.H. 2007. First report of the emergence of CTX-M-type extended-spectrum β–lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob. Agents Chemother. 51:4015–4021.
21.
FangH., AtakerF., HedinG., and DornbuschK.. 2008. Molecular epidemiology of extended-spectrum-lactamases among Escherichia coli isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006. J. Clin. Microbiol. 46:707–712.
22.
WolfensbergerA., KusterS.P, MarchesiM., ZbindenR., and HombachM.. 2019. The effect of varying multidrug-resistance (MDR) definitions on rates of MDR gram-negative rods. Antimicrob. Resist. Infect. Control, 8:193.
23.
and WHOFAO. 2019. Joint FAO/WHO Expert Meeting in collaboration with OIE on Foodborne Antimicrobial Resistance: Role of the Environment, Crops and Biocides—Meeting report. Microbiological Risk Assessment Series no. 34. Rome.
24.
BergšpicaI., KaprouG., AlexaE.A., PrietoM., and Alvarez-OrdóñezA.. 2020. Extended spectrum beta-lactamase (ESBL) producing Escherichia coli in pigs and pork meat in European Union. Antibiotics, 9:678.
25.
HölzelC.S., HarmsK.S, KüchenhoffH., et al.2010. Phenotypic and genotypic bacterial antimicrobial resistance in liquid pig manure is variously associated with contents of tetracyclines and sulphonamides. J. Appl. Microbiol. 108:1642–1656.
26.
ÖsterbergJ., WingstrandA., JensenA.N, et al.2016. Antibiotic resistance in Escherichia coli from pigs in organic and conventional farming in four European countries. PLos One, 11:e0157049.
27.
LiP., WuD., LiuK., et al.2014. Investigation of antimicrobial resistance in Escherichia coli and Enterococci isolated from Tibetan pigs. PLos One, 9:e95623.
28.
LiuX., LiuH., WangL., et al. 2018. Molecular characterization of extended-spectrum beta-lactamase-producing multidrug resistant, Escherichia coli, from swine in Northwest China. Front. Microbiol. 9: , 1756.
29.
LugsomyaK., YindeeJ., NiyomthamW., et al.2018. Antimicrobial resistance in commensal Escherichia coli isolated from pigs and pork derived from farms either routinely using or not using in-feed antimicrobials. Microbial. Drug Resist. 24:1054–1066.
30.
AbubakarR., MadorobaE., AdebowaleO., FasanmiO.G, and FasinaF.O.. 2019. Antimicrobial usage in pig production: effects on Escherichia coli virulence profiles and antimicrobial resistance. Onderstepoort J. Vet. Res. 86:a1743.
31.
BurowE., RostalskiA., HarliziusJ., et al.2019. Antibiotic resistance in Escherichia coli from pigs from birth to slaughter and its association with antibiotic treatment. Prev. Vet. Med. 165:52–62.
32.
FournierC., Aires-de-SousaM., NordmannP., and PoirelL.. 2020. Ocurrence of CTX-M-15- and MCR-1-producing Enterobacteriales in pigs in Portugal: evidence of direct links with antibiotic selective pressure. Int. J. Antimicrob. Agents, 55:105802.
33.
AmadorP.P., FernandesR.M, PrudêncioM.C, BarretoM.P, and DuarteI.M.. 2015. Antibiotic resistance in wastewater: occurrence and fate of Enterobacteriaceae producers of class A and class C beta-lactamases. J. Environ. Sci. Health, 50:26–39.
34.
BörjessonS., NyS., EgervärnM., et al.2016. Limited dissemination of extended-spectrum beta-lactamase- and plasmid-encoded AmpC-producing Escherichia coli from food and farm animals, Sweden. Emerg. Infect. Dis. 22:634–640.
35.
GhoshK.K., LebertL.A, McEwenS.A, et al. 2019. Extended –spectrum beta lactamase and AmpC beta-lactamase-producing Escherichia coli isolates from chickens raised in small flocks in Ontario, Canada. Microbial. Drug Resist. 25:1250–1256.
36.
SabiaC., StefaniS., MessiP., et al.2017. Extended-spectrum beta-lactamase and plasmid-mediated AmpC genes in swine and ground pork. J. Food Safety, 37:e12282.
37.
VelasovaM., SmithR.P, LemnaF., et al.2019. Detection of extended-spectrum beta-lactam, AmpC and carbapenem resistance in Enterobacteriaceae in beef cattle in Great Britain in 2015. J. Appl. Microbiol. 126:1081–1095.
38.
DohmenW., Dorado-GarcíaA., BontenM.J, WagenaarJ.A, MeviusD.J, and HeederikD.J.J. 2017. Risk factors for ESBL-producing Escherichia coli on pig farms: a longitudinal study in the context of reduced use of antimicrobials. PLos One, 12:e0174094.
